Area of research
Pathology and Forensic Medicine · Cancer Research
Research interest
Research focused on Cancer research and Peroxiredoxin, with related work in ARID1A, PI3K/AKT/mTOR pathway, Sting. Notable publications include 'STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer', 'Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells', and 'Pan-cancer analysis of ARID1A Alterations as Biomarkers for Immunotherapy Outcomes'.
PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway
STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer
Pan-cancer analysis of <i>ARID1A</i> Alterations as Biomarkers for Immunotherapy Outcomes
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells